Literature DB >> 389168

Relief of intractable pruritus with naloxone.

J E Bernstein, R Swift.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 389168

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


× No keyword cloud information.
  17 in total

Review 1.  The central opioid system in liver disease and its complications.

Authors:  C Yurdaydin
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

2.  Why do cholestatic patients itch?

Authors:  E A Jones; N V Bergasa
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

Review 3.  Clinical applications of commonly used contemporary antidotes. A US perspective.

Authors:  C A Bowden; E P Krenzelok
Journal:  Drug Saf       Date:  1997-01       Impact factor: 5.606

Review 4.  Cutaneous manifestations of common liver diseases.

Authors:  Sunil Dogra; Rashmi Jindal
Journal:  J Clin Exp Hepatol       Date:  2012-01-02

Review 5.  Pruritus: management algorithms and experimental therapies.

Authors:  Martin Steinhoff; Ferda Cevikbas; Akihiko Ikoma; Timothy G Berger
Journal:  Semin Cutan Med Surg       Date:  2011-06

Review 6.  Naloxone: new therapeutic roles.

Authors:  B Milne; K Jhamandas
Journal:  Can Anaesth Soc J       Date:  1984-05

7.  Intraspinal opiates and itching: a new reflex?

Authors:  P V Scott; H B Fischer
Journal:  Br Med J (Clin Res Ed)       Date:  1982-04-03

Review 8.  Spinal opiate analgesia and facial pruritus: a neural theory.

Authors:  P V Scott; H B Fischer
Journal:  Postgrad Med J       Date:  1982-09       Impact factor: 2.401

Review 9.  Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics.

Authors:  Mellar Davis
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 10.  Pathogenesis and treatment of pruritus in cholestasis.

Authors:  Andreas E Kremer; Ulrich Beuers; Ronald P J Oude-Elferink; Thomas Pusl
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.